About Us
The Story Behind Linkfar
LINKFAR — Innovating at the Edge of Medical Precision
Linkfar’s journey began over 30 years ago as a dedicated manufacturer of blood lancets. Today, we have grown into a comprehensive medical device company with two major business lines — Diabetes Care and Professional Capillary Blood Collection. As one of the world’s most professional manufacturers of safety lancets, we continue to advance precision, safety, and comfort in every sampling solution we create.
Our Dual Focus
- Diabetes Care Line — Lancets, lancing devices, insulin pen needles, CGM accessories, alcohol pads.
- Capillary Blood Collection Line — Safety lancets, neonatal heel blades, micro & capillary tubes, and integrated sampling kits.
Why choose us
EU Regulatory Expertise
We work with a strong understanding of EU MDR and CE requirements across medical consumables. Our teams support regulatory alignment throughout production, not only at initial approval stages.
Certified Quality Systems
All manufacturing activities operate under ISO 13485–certified quality management systems. We emphasize documentation, traceability, and risk-based quality control as part of daily operations.
Multi-Category OEM
Our OEM and ODM experience covers blood collection, diabetes care, and related medical consumable categories. This allows flexible collaboration across different product families and market needs.
Scalable Manufacturing Capability
Our facilities are built to support both pilot projects and long-term, high-volume production. We focus on process stability and consistency to ensure reliable supply over time.
Engineering Collaboration Mindset
We collaborate closely with partners’ engineering and regulatory teams during design, validation, and optimization stages. This approach helps reduce development risk and improve manufacturability.
Trusted Global Partnerships
We have experience working with international healthcare brands across different regulatory environments. This enables smoother communication, audit readiness, and alignment with global procurement expectations.